ESC 365 - Is SiGLT2i the treatment for diabetic cardiomyopathy?

HFA Premium Access

Is SiGLT2i the treatment for diabetic cardiomyopathy?

Session: Heart failure management in the cardiometabolic era

Topic: Comorbidities

Speaker: Doctor J. Ferreira (Porto, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Joao Pedro Ferreira

University of Porto, Porto (Portugal)

7 presentations

3 followers

3 more presentations in this session

Obese cardiomyopathy and the role of GLP-1

Speaker: Professor J. Butler (Dallas, US)

How to manage heart failure in uremic cardiomyopathy

Speaker: Doctor I. Beldhuis (Groningen, NL)

Heart failure management in the cardiometabolic era - discussion

Access the full session

Heart failure management in the cardiometabolic era

Speakers: Doctor J. Ferreira, Professor J. Butler, Doctor I. Beldhuis

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources